Hallway Conversations is a series of audio podcasts with thought leaders and newsmakers in the field of epilepsy on a range of seizure related topics. The series covers a range of topics and are intended to address a wide range of audiences.

We hope that you find the series informative and helpful and that you join us in listening on a regular basis.

 Dr. Joseph Sirven, Editor-in-Chief

Summer Camps and Epilepsy

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Patricia Dean, ARNP, MSN, from the Brain Institute at Miami Childrens Hospital, and Sandra Cushner Weinstein, PT, LICSW, LCSW-C, Director of Services and Camps, Department of Neurology, at George Washington University School of Medicine. With summer rapidly approaching, they will be talking about Epilepsy Camps. After the interview, you can find out more on the Brainy Camps webpage (www.brainycamps.com) and on the epilepsy.com summer camp section (www.epilepsy.com/get-help/managing-your-epilepsy/summer-camp).

SAGE Trial for Refractory Status Epilepticus

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Steve Kanes, MD, PhD, Chief Medical Officer at SAGE Therapeutics about the SAGE 547 Trial in Status Epilepticus. SAGE-547 is currently being evaluated in a Phase 1/2 clinical trial for super-refractory status epilepticus (SRSE). SAGE-547 demonstrated robust findings in preclinical models of SE, including significantly increased efficacy over current standard-of-care benzodiazepine treatment, and compelling early human experience data. After the interview, you can learn more about refractory epilepsy at: http://www.epilepsy.com/learn/refractory-epilepsy.

The Latest Innovations in Treating Epilepsy: Visualase

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Julian Bailes, MD, co-Director of the NorthShore University HealthSystem Neurological Institute based in Evanston, IL. They are talking about one of the latest innovations in treating epilepsy, the minimally-invasive surgery, Visualase. The Visualase System is an MRI-guided laser system for minimally invasive surgery. Visualase, Inc. was awarded a New Therapy Grant from the Epilepsy Foundation/Epilepsy Therapy Project in December 2010.

Veterans With Epilepsy - POEM Study

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews John Hixson, MD about the Policy for Optimal Epilepsy Management (POEM) study. The overall goal of the study is to improve the self-management practices of U.S. Veterans with epilepsy such as tracking seizures, managing medications and side effects, and engaging with other people with similar concerns about their condition. The results of the study were presented at the 66th Annual Meeting of the American Academy of Neurology.

International Epilepsy Clinics

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Andrew Wilner, MD about international epilepsy clinics

Pages